Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cataract surgery and inflammation – the role of preoperative NSAIDs (pre-CIN)
2024-512268-77-00Phase 4Authorised
- Sponsor
- Oslo University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nepafenac and HiDex in cataract (4 arms), sponsored by Oslo University Hospital. Primary endpoint: Laser flare. Planned start Oct 2024; status: authorised.
02
Drugs
nepafenacHiDex
03
Conditions
cataract
Beyond the preview
Go deeper on 2024-512268-77-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512268-77-00.